1. Koch-Weser J (1976) Diazoxide. N Engl J Med 294: 1271-1274
2. Meissner T, Brune W, Mayatepek E (1997) Persistent hyperinsulinaemic hypoglycaemia of infancy: therapy, clinical outcome and mutational analysis. Eur J Pediatr 156: 754-757
3. Vlahos WD, Seemayer TA, Yale JF (1991) Diabetes prevention in BB rats by inhibition of endogenous insulin secretion. Metabolism 40: 825-829
4. Alemzadeh R, Slonim AE, Zdanowicz ML, Maturo J (1993) Modification of insulin resistance by diazoxide in obese Zucker rats. Endocrinology 133: 705-712
5. Aizawa T, Taguchi N, Sato Y et al. (1995) Prophylaxis of genetically determined diabetes by diazoxide: a study in a rat model of naturally occuring obese diabetes. J Pharmacol Exp Ther 275: 194-199
6. Greenwood RH, Mahler RF, Hales CN (1976) Improvement in insulin secretion in diabetes after diazoxide. Lancet 28: 444-447
7. Björk E, Berne C, Kämpe O, Wibell L, Oskarsson P, Karlsson FA (1996) Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes. Diabetes 45: 1427-1430
8. Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE (1998) Beneficial effect of diazoxide in obese hyperinsulinemic adults. J Clin Endocrinol Metab 83: 1911-1915
9. Babenko AP, Aguilar-Bryan L, Bryan J (1998) A view of SUR/ KIR 6.X, KATP channels. Annu Rev Physiol 60: 667-687
10. Ashcroft FM, Rorsman P (1989) Electrophysiology of the pancreatic B-cell. Prog Biophys Mol Biol 54: 87-143
11. Lebrun P, Antoine M-H, Herchuelz A (1992) Minireview: K+ channel openers and insulin release. Life Sci 51: 795-806
12. Ashcroft FM, Gribble FM (1998) Correlating structure and function in ATP-sensitive K+ channels. Trends Neurosci 21: 288-294
13. Leclercq-Meyer V, Marchand J, Woussen-Colle MC, Giroix MH, Malaisse WJ (1985) Multiple effects of leucine on glucagon, insulin and somatostatin secretion from the perifused rat pancreas. Endocrinology 116: 1168-1174
14. Lebrun P, Malaisse WJ, Herchuelz A (1982a) Evidence for two distinct modalities of Ca2+ influx into pancreatic B cell. Am J Physiol 242: E59-E66
15. Lebrun P, Malaisse WJ, Herchuelz A (1982b) Nutrient-induced intracellular calcium movement in rat pancreatic B cell. Am J Physiol 243: E196-E205
16. Lebrun P, Devreux V, Hermann M, Herchuelz A (1989) Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets. J Pharmacol Exp Ther 250: 1011-1018
17. Lebrun P, Antoine M-H, Ouedraogo R et al. (1996) Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62. J Pharmacol Exp Ther 277: 156-162
18. Malaisse WJ, Boschero AC, Kawazu S, Hutton JC (1978) The stimulus secretion coupling of glucose-induced insulin release. XXVII. Effect of glucose on K+ fluxes in isolated islets. Pflügers Arch 373: 237-242
19. Efrat S, Linde S, Kofod H et al. (1988) Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 85: 9037-9041
20. Epps DE, Wolfe ML, Groppi V (1994) Characterization of the steady state and the dynamic fluorescence properties of the potential-sensitive dye bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC4(3)) in model systems and cells. Chem Phys Lipids 69: 137-150
21. Antoine MH, Berkenboom G, Fang ZY, Fontaine J, Herchuelz A, Lebrun P (1992) Mechanical and ionic response of rat aorta to diazoxide. Eur J Pharmacol 216: 299-306
22. de Tullio P, Pirotte B, Lebrun et al. (1996) 3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships. J Med Chem 39: 937-948
23. Pirotte B, de Tullio P, Lebrun P et al. (1993) 3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: a new class of potassium channel openers? J Med Chem 36: 3211-3213
24. Di Bella M, Rinaldi M, Fabio U, Manicardi G (1973) Azione antimicrobica di derivati dell' 1,2,4-benzotiadiazin-1,1-diossido. Farmaco 28: 411-417
25. Raffa L, Di Bella M, Ferrari P, Rinaldi M (1974) Azione cardiovascolare di derivati dell' 1,2,4-benzothiadiazin-1,1-diossido. Farmaco 29: 411-423
26. Lebrun P, Atwater I (1985) Effects of the calcium channel agonist, BAY K 8644, on electrical activity in mouse pancreatic B-cells. Biophys J 48: 919-930
27. Girard Y, Atkinson JG, Rokach J (1979) A new synthesis of 1, 2, 4-benzothiadiazines and a selective preparation of o-aminobenzenesulphonamides. J Chem Soc [Perkin 1]: 1043-1047
28. Godfraind T, Miller R, Wibo M (1986) Calcium antagonism and calcium entry blockade. Pharmacol Rev 38: 321-416
29. Henquin JC, Debuyser A, Drews G, Plant TD (1992) Regulation of K+ permeability and membrane potential in insulin secreting cells. In: Flatt PR (ed) Nutrient regulation of insulin secretion. Portland Press, London, pp 173-191
30. Malaisse WJ, Lebrun P (1990) Mechanisms of sulfonylurea-induced insulin release. Diabetes Care 13[Suppl 3]:9-17
31. Plasman P-O, Hermann M, Herchuelz A, Lebrun P (1990) Sensitivity to Cd2+ but resistance to Ni2+ of Ca2+ inflow into rat pancreatic islets. Am J Physiol 258: E529-E533
32. Antoine M-H, Ouedraogo R, Sergooris J, Hermann M, Herchuelz A, Lebrun P (1996) Hydroxylamine, a nitric oxide donor, inhibits insulin release and activates K+ATP channels. Eur J Pharmacol 313: 229-235
